
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| LOP_L | 3,121 | 98.9% | -0.14 | 2,835 | 99.4% |
| LO_L | 34 | 1.1% | -1.00 | 17 | 0.6% |
| upstream partner | # | NT | conns LPi03 | % In | CV |
|---|---|---|---|---|---|
| T5c (L) | 196 | ACh | 96.3 | 20.6% | 0.7 |
| T4c (L) | 196 | ACh | 72.8 | 15.6% | 0.7 |
| Y3 (L) | 65 | ACh | 39.2 | 8.4% | 0.6 |
| LPi13 (L) | 1 | GABA | 38.3 | 8.2% | 0.0 |
| MeLp2 (R) | 1 | Unk | 23.7 | 5.1% | 0.0 |
| LPi03 (L) | 6 | Unk | 13.3 | 2.9% | 0.4 |
| TmY5a (L) | 41 | Glu | 10.3 | 2.2% | 0.6 |
| TmY3 (L) | 33 | ACh | 10.2 | 2.2% | 0.6 |
| LPi11 (L) | 9 | GABA | 10 | 2.1% | 1.3 |
| TmY4 (L) | 26 | ACh | 9.5 | 2.0% | 0.6 |
| LC14b (R) | 7 | ACh | 8.2 | 1.7% | 1.2 |
| LPT58 (R) | 1 | ACh | 8.2 | 1.7% | 0.0 |
| LLPt (L) | 18 | GABA | 8.2 | 1.7% | 0.4 |
| Am1 (L) | 1 | GABA | 7 | 1.5% | 0.0 |
| Y11 (L) | 19 | Glu | 6.3 | 1.4% | 0.6 |
| mALC5 (R) | 1 | GABA | 5.5 | 1.2% | 0.0 |
| LPT48_vCal3 (L) | 1 | ACh | 5.3 | 1.1% | 0.0 |
| T4d (L) | 23 | ACh | 5 | 1.1% | 0.5 |
| Y12 (L) | 14 | Glu | 4 | 0.9% | 0.6 |
| LLPC3 (L) | 11 | ACh | 3.7 | 0.8% | 0.5 |
| LPi01 (L) | 12 | Glu | 3.7 | 0.8% | 0.6 |
| Tlp4 (L) | 9 | Glu | 3.5 | 0.7% | 0.7 |
| T4b (L) | 14 | ACh | 3.3 | 0.7% | 0.7 |
| LPC1 (L) | 10 | ACh | 3.2 | 0.7% | 0.5 |
| Tlp14 (L) | 9 | Glu | 3 | 0.6% | 0.5 |
| Tlp5 (L) | 6 | Glu | 3 | 0.6% | 0.4 |
| LPi04 (L) | 12 | Glu | 2.8 | 0.6% | 0.5 |
| T5d (L) | 15 | ACh | 2.8 | 0.6% | 0.3 |
| Tm4 (L) | 4 | ACh | 2.7 | 0.6% | 1.0 |
| LPT22 (L) | 1 | GABA | 2.5 | 0.5% | 0.0 |
| LPi07 (L) | 7 | GABA | 2.5 | 0.5% | 0.6 |
| cLP03 (L) | 7 | GABA | 2.3 | 0.5% | 0.8 |
| T5b (L) | 10 | ACh | 2.3 | 0.5% | 0.3 |
| LPi10 (L) | 9 | Glu | 2.3 | 0.5% | 0.3 |
| LPT30 (L) | 1 | ACh | 2.2 | 0.5% | 0.0 |
| Tlp1 (L) | 9 | Glu | 2.2 | 0.5% | 0.7 |
| LPi14 (L) | 2 | GABA | 2 | 0.4% | 0.7 |
| LPi05 (L) | 7 | Glu | 2 | 0.4% | 0.4 |
| LPT21 (L) | 1 | ACh | 1.8 | 0.4% | 0.0 |
| LLPC2 (L) | 8 | ACh | 1.8 | 0.4% | 0.5 |
| LPi09 (L) | 8 | Unk | 1.8 | 0.4% | 0.4 |
| LPC2 (L) | 5 | ACh | 1.7 | 0.4% | 0.5 |
| LMa4 (L) | 3 | GABA | 1.7 | 0.4% | 0.8 |
| Y1 (L) | 5 | Glu | 1.3 | 0.3% | 0.3 |
| LPT57 (R) | 1 | ACh | 1.2 | 0.2% | 0.0 |
| LPLC1 (L) | 6 | ACh | 1.2 | 0.2% | 0.3 |
| TmY15 (L) | 6 | GABA | 1.2 | 0.2% | 0.3 |
| LPT54 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| TmY20 (L) | 5 | ACh | 1 | 0.2% | 0.3 |
| LPi08 (L) | 3 | GABA | 1 | 0.2% | 0.4 |
| TmY31 (L) | 5 | ACh | 1 | 0.2% | 0.3 |
| LPi06 (L) | 3 | Glu | 1 | 0.2% | 0.7 |
| TmY14 (L) | 6 | Glu | 1 | 0.2% | 0.0 |
| TmY9q (L) | 3 | ACh | 0.8 | 0.2% | 0.6 |
| VST2 (L) | 2 | ACh | 0.8 | 0.2% | 0.6 |
| cLP05 (R) | 1 | Unk | 0.8 | 0.2% | 0.0 |
| TmY11 (L) | 4 | ACh | 0.8 | 0.2% | 0.3 |
| cLP01 (L) | 3 | GABA | 0.8 | 0.2% | 0.6 |
| OA-AL2i1 (L) | 1 | OA | 0.7 | 0.1% | 0.0 |
| LPi15 (L) | 1 | GABA | 0.7 | 0.1% | 0.0 |
| LPT50 (R) | 1 | GABA | 0.7 | 0.1% | 0.0 |
| MeLp1 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| LPi02 (L) | 2 | Glu | 0.5 | 0.1% | 0.3 |
| LPT45_dCal1 (R) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| LPLC4 (L) | 3 | ACh | 0.5 | 0.1% | 0.0 |
| LPLC2 (L) | 3 | ACh | 0.5 | 0.1% | 0.0 |
| cLP02 (L) | 3 | GABA | 0.5 | 0.1% | 0.0 |
| TmY10 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| T2 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| LPT50 (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| LPT27 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| LLPC1 (L) | 2 | ACh | 0.3 | 0.1% | 0.0 |
| MeMe_e08 (R) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| TmY16 (L) | 2 | Unk | 0.3 | 0.1% | 0.0 |
| LPT23 (L) | 2 | ACh | 0.3 | 0.1% | 0.0 |
| LPT49 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| TmY9q__perp (L) | 2 | ACh | 0.3 | 0.1% | 0.0 |
| H2 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| cLP04 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| LPTe02 (L) | 1 | Unk | 0.2 | 0.0% | 0.0 |
| T4a (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| Tm1 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| DNc01 (R) | 1 | DA | 0.2 | 0.0% | 0.0 |
| cLPL01 (R) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| Tm3 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| LPT47_vCal2 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| cLLPM02 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| VS4 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| VST1 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| LPT45_dCal1 (L) | 1 | GABA | 0.2 | 0.0% | 0.0 |
| T5a (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| downstream partner | # | NT | conns LPi03 | % Out | CV |
|---|---|---|---|---|---|
| LPT30 (L) | 1 | ACh | 37.5 | 14.7% | 0.0 |
| vCal1 (L) | 1 | Glu | 16.8 | 6.6% | 0.0 |
| LLPC3 (L) | 27 | ACh | 15 | 5.9% | 0.9 |
| LLPt (L) | 18 | GABA | 14.2 | 5.6% | 0.8 |
| LPi03 (L) | 6 | Unk | 13.3 | 5.2% | 0.4 |
| LPT21 (L) | 1 | ACh | 12.5 | 4.9% | 0.0 |
| LPT31 (L) | 4 | ACh | 11.8 | 4.6% | 0.4 |
| Tlp1 (L) | 20 | Glu | 9.7 | 3.8% | 0.6 |
| LPLC4 (L) | 13 | ACh | 9.3 | 3.7% | 0.6 |
| Y12 (L) | 26 | Glu | 8.3 | 3.3% | 0.6 |
| TmY14 (L) | 27 | Glu | 7.8 | 3.1% | 0.7 |
| TmY5a (L) | 32 | Glu | 6.8 | 2.7% | 0.4 |
| LPi10 (L) | 17 | Glu | 5.8 | 2.3% | 0.8 |
| LPLC1 (L) | 12 | ACh | 5.7 | 2.2% | 1.0 |
| LPi04 (L) | 9 | Glu | 5.5 | 2.2% | 0.7 |
| TmY31 (L) | 15 | ACh | 5.3 | 2.1% | 0.8 |
| LPi05 (L) | 10 | Glu | 4.7 | 1.8% | 0.6 |
| LPT49 (L) | 1 | ACh | 3.7 | 1.4% | 0.0 |
| LPi07 (L) | 10 | GABA | 3.2 | 1.2% | 0.4 |
| LPC1 (L) | 14 | ACh | 3.2 | 1.2% | 0.5 |
| LPT23 (L) | 3 | ACh | 3 | 1.2% | 0.4 |
| T4b (L) | 11 | ACh | 2.7 | 1.0% | 0.3 |
| LPT52 (L) | 1 | ACh | 2.5 | 1.0% | 0.0 |
| LLPC2 (L) | 10 | ACh | 2.5 | 1.0% | 0.5 |
| LPT54 (L) | 1 | ACh | 2.3 | 0.9% | 0.0 |
| T4c (L) | 14 | ACh | 2.3 | 0.9% | 0.0 |
| LPT47_vCal2 (L) | 1 | Glu | 2 | 0.8% | 0.0 |
| Y11 (L) | 8 | Glu | 1.8 | 0.7% | 0.5 |
| T5c (L) | 10 | ACh | 1.8 | 0.7% | 0.3 |
| LLPC1 (L) | 9 | ACh | 1.7 | 0.7% | 0.3 |
| T4d (L) | 8 | ACh | 1.5 | 0.6% | 0.3 |
| T5d (L) | 9 | ACh | 1.5 | 0.6% | 0.0 |
| LPi13 (L) | 1 | GABA | 1.3 | 0.5% | 0.0 |
| Am1 (L) | 1 | GABA | 1.3 | 0.5% | 0.0 |
| LPT48_vCal3 (L) | 1 | ACh | 1.3 | 0.5% | 0.0 |
| LPi02 (L) | 5 | Glu | 1.3 | 0.5% | 0.8 |
| Y3 (L) | 6 | ACh | 1.3 | 0.5% | 0.6 |
| T5b (L) | 7 | ACh | 1.3 | 0.5% | 0.3 |
| LPi09 (L) | 6 | GABA | 1.2 | 0.5% | 0.3 |
| VST2 (L) | 3 | ACh | 1.2 | 0.5% | 0.5 |
| LPLC2 (L) | 6 | ACh | 1.2 | 0.5% | 0.3 |
| LPi11 (L) | 4 | GABA | 1 | 0.4% | 0.3 |
| T4a (L) | 5 | ACh | 1 | 0.4% | 0.3 |
| Y1 (L) | 6 | Glu | 1 | 0.4% | 0.0 |
| TmY4 (L) | 5 | ACh | 1 | 0.4% | 0.3 |
| cLP03 (L) | 2 | GABA | 0.8 | 0.3% | 0.6 |
| Tlp14 (L) | 4 | Glu | 0.8 | 0.3% | 0.3 |
| TmY20 (L) | 5 | ACh | 0.8 | 0.3% | 0.0 |
| LPC2 (L) | 5 | ACh | 0.8 | 0.3% | 0.0 |
| LPi01 (L) | 5 | Glu | 0.8 | 0.3% | 0.0 |
| TmY3 (L) | 4 | ACh | 0.7 | 0.3% | 0.0 |
| Tlp4 (L) | 4 | Glu | 0.7 | 0.3% | 0.0 |
| LPi15 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| LPT22 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| MeLp2 (R) | 1 | Unk | 0.5 | 0.2% | 0.0 |
| Tlp5 (L) | 2 | Glu | 0.5 | 0.2% | 0.3 |
| TmY10 (L) | 2 | ACh | 0.5 | 0.2% | 0.3 |
| TmY15 (L) | 3 | GABA | 0.5 | 0.2% | 0.0 |
| T5a (L) | 3 | ACh | 0.5 | 0.2% | 0.0 |
| VSm (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| Nod3 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| TmY11 (L) | 2 | ACh | 0.3 | 0.1% | 0.0 |
| H1 (L) | 1 | Unk | 0.3 | 0.1% | 0.0 |
| LMt1 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| LPT42_Nod4 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| LPi06 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| cLP04 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| LPi14 (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| cL03 (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| LPT50 (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| cLPL01 (R) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| MeLp1 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| cLP02 (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| LPi08 (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| VCH (R) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| Tm27 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| TmY16 (L) | 1 | Unk | 0.2 | 0.1% | 0.0 |
| Tm5f (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| TmY9q__perp (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| LC14b (R) | 1 | ACh | 0.2 | 0.1% | 0.0 |